Healthcare Sector
Through AID Genomics, the group operates one of the most proven healthcare technology platforms in the region. Our capabilities in genomics testing, clinical data infrastructure, and rapid facility deployment have been validated at global scale.
AID Group's healthcare investments focus on technology-enabled healthcare — platforms and infrastructure that fundamentally improve the speed, accuracy, and accessibility of medical services.
AID Genomics built one of the world's largest PCR testing facilities in Jerusalem — processing 80,000 tests per day with 250 technicians across a 25,000 sq ft facility.
The facility was constructed in just 45 days, demonstrating AID Group's ability to deploy complex healthcare infrastructure at extraordinary speed when circumstances demand it.
The operation was led by CEO Snir Zano, whose combination of Israeli military logistics training and entrepreneurial drive made the rapid deployment possible.
Building on the proven Jerusalem infrastructure, AID Genomics is expanding into African markets — bringing affordable, high-throughput genomics testing to regions with critical unmet healthcare needs.
Our Clinical Data Parser platform enables multilingual clinical data extraction in English, Hebrew, Japanese, and Chinese — supporting healthcare operations across all of AID Group's geographic markets.
Healthcare represents one of AID Group's highest-conviction investment themes. We believe that technology-enabled healthcare — particularly genomics, diagnostics, and AI-powered clinical tools — will be among the most transformative sectors of the coming decade.
We seek healthcare investments that combine proven technology with clear paths to scale globally. If you are building in this space, contact us at info@aidg.com